5 minute read
Sep. 24, 2022
Billion-Dollar Molecules: Avacopan (Tavneos), a First-in-Class C5aR Antagonist Acquired by Amgen
Reviewer:
Welcome to Phase III of Drug Hunter! Pardon our dust and please report any issues you encounter to support@drughunter.com.